Unknown

Dataset Information

0

Erythropoietin-Modified Mesenchymal Stem Cells Enhance Anti-fibrosis Efficacy in Mouse Liver Fibrosis Model.


ABSTRACT:

Background

Mesenchymal stem cell (MSC)-based cell transplantation is an effective means of treating chronic liver injury, fibrosis and end-stage liver disease. However, extensive studies have found that only a small number of transplanted cells migrate to the site of injury or lesion, and repair efficacy is very limited.

Methods

Bone marrow-derived MSCs (BM-MSCs) were generated that overexpressed the erythropoietin (EPO) gene using a lentivirus. Cell Counting Kit-8 was used to detect the viability of BM-MSCs after overexpressing EPO. Cell migration and apoptosis were verified using Boyden chamber and flow cytometry, respectively. Finally, the anti-fibrosis efficacy of EPO-MSCs was evaluated in vivo using immunohistochemical analysis.

Results

EPO overexpression promoted cell viability and migration of BM-MSCs without inducing apoptosis, and EPO-MSC treatment significantly alleviated liver fibrosis in a carbon tetrachloride (CCl4) induced mouse liver fibrosis model.

Conclusion

EPO-MSCs enhance anti-fibrotic efficacy, with higher cell viability and stronger migration ability compared with treatment with BM-MSCs only. These findings support improving the efficiency of MSCs transplantation as a potential therapeutic strategy for liver fibrosis.

SUBMITTER: Wang X 

PROVIDER: S-EPMC7333789 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7882891 | biostudies-literature
| S-EPMC5542197 | biostudies-literature
| S-EPMC7347778 | biostudies-literature
| S-EPMC4672342 | biostudies-literature
| S-EPMC7792122 | biostudies-literature
| S-EPMC7523343 | biostudies-literature
| S-EPMC6079241 | biostudies-literature
| S-EPMC5971352 | biostudies-literature
| S-EPMC4323372 | biostudies-literature
| S-EPMC4460871 | biostudies-other